Published in J Infect Dis on November 15, 2007
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol (2009) 1.94
Forty-five years of Marburg virus research. Viruses (2012) 1.34
Biotechnological applications of recombinant single-domain antibody fragments. Microb Cell Fact (2011) 1.16
Clinical aspects of Marburg hemorrhagic fever. Future Virol (2011) 1.06
Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents. PLoS One (2010) 1.01
Llama-derived single domain antibodies specific for Abrus agglutinin. Toxins (Basel) (2011) 0.96
Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex. Anal Chem (2008) 0.95
Nanobody binding to a conserved epitope promotes norovirus particle disassembly. J Virol (2014) 0.94
Isolation of a highly thermal stable lama single domain antibody specific for Staphylococcus aureus enterotoxin B. BMC Biotechnol (2011) 0.92
Ricin detection using phage displayed single domain antibodies. Sensors (Basel) (2009) 0.86
Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation. PLoS One (2013) 0.84
Hapten mediated display and pairing of recombinant antibodies accelerates assay assembly for biothreat countermeasures. Sci Rep (2012) 0.82
Evaluation of antidiphtheria toxin nanobodies. Nanotechnol Sci Appl (2010) 0.79
Linking Single Domain Antibodies that Recognize Different Epitopes on the Same Target. Biosensors (Basel) (2012) 0.78
Novel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: a prototype for an early diagnosis of Hantavirus Pulmonary Syndrome. PLoS One (2014) 0.77
Conjugation of biotin-coated luminescent quantum dots with single domain antibody-rhizavidin fusions. Biotechnol Rep (Amst) (2016) 0.75
Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview. Front Immunol (2017) 0.75
From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein. Microb Cell Fact (2017) 0.75
Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging. Front Immunol (2017) 0.75
Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies. Front Immunol (2017) 0.75
Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science (2004) 3.08
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat Biotechnol (2002) 2.77
Viral assembly of oriented quantum dot nanowires. Proc Natl Acad Sci U S A (2003) 2.00
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc Natl Acad Sci U S A (2004) 1.54
Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol (2006) 1.50
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J Virol (2005) 1.42
A hybrid quantum dot-antibody fragment fluorescence resonance energy transfer-based TNT sensor. J Am Chem Soc (2005) 1.41
Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. Anal Chem (2006) 1.39
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One (2013) 1.38
Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res (2002) 1.29
Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infect Immun (2005) 1.28
Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol (2014) 1.27
Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase. Sci Transl Med (2012) 1.24
Protection against lethal challenge by Ebola virus-like particles produced in insect cells. Virology (2008) 1.22
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol (2013) 1.16
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine (2007) 1.13
Filoviruses utilize glycosaminoglycans for their attachment to target cells. J Virol (2013) 1.11
Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers. Emerg Infect Dis (2009) 1.11
Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J Virol (2008) 1.10
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol (2013) 1.10
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine (2008) 1.09
The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment. Viruses (2012) 1.08
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology (2006) 1.06
A small nonhuman primate model for filovirus-induced disease. Virology (2011) 1.03
Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents. PLoS One (2010) 1.01
Short report: quantification of leishmaniavirus RNA in clinical samples and its possible role in pathogenesis. Am J Trop Med Hyg (2003) 1.00
RNA binding domain of Jamestown Canyon virus S segment RNAs. J Virol (2007) 0.99
A novel adenovirus species associated with an acute respiratory outbreak in a baboon colony and evidence of coincident human infection. MBio (2013) 0.98
Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin Vaccine Immunol (2009) 0.97
Structures of a key interaction protein from the Trypanosoma brucei editosome in complex with single domain antibodies. J Struct Biol (2010) 0.95
Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex. Anal Chem (2008) 0.95
Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques. J Virol (2015) 0.94
Baboon as a nonhuman primate model for vaccine studies. Vaccine (2005) 0.92
An animal model that reflects human disease: the common marmoset (Callithrix jacchus). Curr Opin Virol (2012) 0.91
Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library. Mol Immunol (2006) 0.90
Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. Vaccine (2010) 0.90
Self-assembled TNT biosensor based on modular multifunctional surface-tethered components. Anal Chem (2005) 0.89
Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection. Am J Trop Med Hyg (2010) 0.88
Architectonics of phage-liposome nanowebs as optimized photosensitizer vehicles for photodynamic cancer therapy. Mol Cancer Ther (2010) 0.87
Multiplexed fluid array screening of phage displayed anti-ricin single domain antibodies for rapid assessment of specificity. Biotechniques (2007) 0.86
Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro. J Virol (2012) 0.86
Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies. Vaccine (2007) 0.86
Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate. PLoS Negl Trop Dis (2013) 0.85
2,4,6-Trinitrotoluene detection using recombinant antibodies. J Environ Monit (2003) 0.84
Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin. Anal Bioanal Chem (2010) 0.84
Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation. PLoS One (2013) 0.84
Ebola virus does not block apoptotic signaling pathways. J Virol (2013) 0.82
Evidence that the fully assembled capsid of Leishmania RNA virus 1-4 possesses catalytically active endoribonuclease activity. Exp Mol Med (2004) 0.82
Hapten mediated display and pairing of recombinant antibodies accelerates assay assembly for biothreat countermeasures. Sci Rep (2012) 0.82
Vaccines against viral hemorrhagic fevers: non-human primate models. Hum Vaccin (2011) 0.82
Experimental cross-species infection of common marmosets by titi monkey adenovirus. PLoS One (2013) 0.80
Luminescent biocompatible quantum dots: a tool for immunosorbent assay design. Methods Mol Biol (2007) 0.79
Purification, identification, and biochemical characterization of a host-encoded cysteine protease that cleaves a leishmaniavirus gag-pol polyprotein. J Virol (2003) 0.78
Sequence variability in viral genome non-coding regions likely contribute to observed differences in viral replication amongst MARV strains. Virology (2013) 0.76
Re: 'Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin' by Garcia-Rodriguez et al., PEDS, 2011;24:321-331. Protein Eng Des Sel (2011) 0.76
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res (2012) 0.76
Building biosafety laboratories. Science (2003) 0.75
Microfluidic System for Detection of Viral RNA in Blood using a Barcode Fluorescence Reporter and a Photo-Cleavable Capture Probe. Anal Chem (2017) 0.75